NEW YORK (GenomeWeb News) – Sanford-Burnham Medical Research Institute said this week that CEO John Reed is leaving his post at the institute to become head of Roche Pharma Research and Early Development and to serve on the firm's corporate executive committee. Sanford-Burnham's current President, Kristiina Vuori, will take over Reed's responsibilities on an interim basis while the institute seeks his replacement.

After the management transition process is complete, Reed will continue to hold an adjunct professor spot with the institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.